Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-30

Clinical Trial Update: A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating biomarkers to predict abatacept efficacy in rheumatoid arthritis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORENCIA (ABATACEPT)

Snippet

Sponsor: University of Washington | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2024-07-30